Predicting painful or difficult intrauterine device insertion in nulligravid women

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 345-353

  Kaislasuo, Janina ^a   Heikinheimo, Oskari ^a   Lähteenmäki, Pekka ^a   Suhonen, Satu ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; CONTRACEPTION; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; NULLIGRAVIDA; PAIN; PAIN ASSESSMENT; PELVIC EXAMINATION; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

ADOLESCENT; ADULT; CERVIX UTERI; DYSMENORRHEA; FEMALE; GENITAL DISEASES, FEMALE; GRAVIDITY; HUMANS; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDICAL HISTORY TAKING; MENSTRUATION; ORGAN SIZE; PAIN; PAIN MEASUREMENT; ROC CURVE; UTERUS; VAGINA; YOUNG ADULT;

EID: 84905115462     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000362     Document Type: Article

References (29)

1. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 539. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:983-8.
2. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Geneva (Switzerland): WHO; 2010.
3. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004;69:407-12.
4. Brockmeyer A Kishen M, Webb A. Experience of IUD/IUS insertions and clinical performance in nulliparous women-a pilot study. Eur J Contracept Reprod Health Care 2008;13:248-54.
5. McNicholas C, Peipert JF. Long-acting reversible contraception for adolescents. Curr Opin Obstet Gynecol 2012;24:293-8.
6. Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. The Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007373. DOI: 10.1002/14651858.CD007373.pub2.
7. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481-6.
8. Hubacher D. Copper intrauterine device use by nulliparous women: review of side effects. Contraception 2007;75(suppl): S8-11.
9. Shipp TD, Bromley B, Benacerraf BR. The width of the uterine cavity is narrower in patients with an embedded intrauterine device (IUD) compared to a normally positioned IUD. J Ultrasound Med 2010;29:1453-6.
10. Canteiro R Bahamondes MV, dos Santos Fernandes A Espejo-Arce X, Marchi NM, Bahamondes L. Length of the endometrial cavity as measured by uterine sounding and ultrasonography in women of different parities. Contraception 2010;81:515-9.
11. Benacerraf BR Shipp TD, Lyons JG, Bromley B. Width of the normal uterine cavity in premenopausal women and effect of parity. Obstet Gynecol 2010;116:305-10.
12. Nova-T380 product information, Bayer Pharma, Turku, Finland. Available at: http://www.bayer.ca/files/MIRENA-PM-ENG-15JUL2013-164011.pdf?#. Retrieved April 15, 2014.
13. Nelson A, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 2013;122:1205-13.
14. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012;97:616-22. e1-3.
15. Bahamondes L, Mansour D, Fiala C, Kaunitz AM, Gemzell-Danielsson K. Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives. J Fam Plann Reprod Health Care 2014;40:54-60.
16. Kaunitz A, Nelson A. Toward optimal intrauterine contraception: update on patient selection and best practices in placement. Available at: http://www.mycme.com/toward-optimal-intrauterine-contraception-update-on- patient-selection-and-best-practices-in-placement/material/1597/5741/. Retrieved April 15, 2014.
17. Maguire K, Morrell K, Westhoff C, Davis A. Accuracy of providers' assessment op pain during intrauterine device insertion. Contraception 2014;89:22-4.
18. Van Schoubroeck D, Van den Bosch T, Ameye L, Veldman J, Hindryckx A, Werbrouck E, et al. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion. Eur J Obstet Gynecol Reprod Biol 2013;171:154-6.
19. Goldstuck ND, Matthews ML. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device. Clin Reprod Fertil 1985;3:65-71.
20. Allen R, Carey M, Raker C, Goyal V, Matteson K. A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries. J Obstet Gynaecol 2014;34:263-7.
21. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing system in nulligravidas. Contraception 2011;84: e11-6.
22. Harvey C, Bateson D, Wattimena J, Black KI. Ease of intrauter-ine contraceptive device insertion in family planning settings. Aust N Z J Obstet Gynaecol 2012;52:534-9.
23. Santos AR, Bahamondes MV, Hidalgo MM, Atti A, Bahamondes L, Monteiro I. Pain at insertion of the levonorgestrel-releasing intrauterine system in nulligravida and parous women with and without cesarean section. Contraception 2013;88:164-8.
24. Dawood M. Dysmenorrhea. J Reprod Med 1985;30:154-67.
25. Celik H, Gurates B, Parmaksiz C, Polat A, Hanay F, Yavuz A, et al. Severity of pain and circadian changes in uterine artery blood flow in primary dysmenorrhea. Arch Gynecol Obstet 2009;280:589-92.
26. Dmitrovic R, Kunselman A, Legro R. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial. Hum Reprod 2013;28:2958-65.
27. Vincent K, Warnaby C, Stagg C, Moore J, Kennedy S, Tracey I. Dysmenorrhoea is associated with central changes in otherwise healthy women. Pain 2011;152:1966-75.
28. Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother 2008;9: 2661-72.
29. Liu P, Duan J, Wang P, Qain D, Guo J, Shang E, et al. Bio-markers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine. Mol Biosyst 2013;9:77-87.